🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Psoriasis is a chronic inflammatory condition driven by a complex interplay...
Status
Recruiting
Location
CHU de Nice - Hôpital de l'Archet
Start Date
2025-07-22
Trial ID
NCT06742333
Treatments Being Tested
Hidradenitis suppurativa (HS) is a painful, long-term skin condition that c...
Status
Completed
Location
Hs0001 121
Start Date
2017-09-22
Trial ID
NCT03248531
Treatments Being Tested
To evaluate the safety of UCB4940 administered by iv infusion of a single a...
Status
Completed
Location
1
Start Date
2012-11
Trial ID
NCT02529956
The purpose of this research study is to evaluate the effectiveness and saf...
Status
Completed
Location
Windsor Dermatology - Psoriasis Treatment Center of Central New Jersey
Start Date
2024-06-03
Trial ID
NCT06336343
Treatments Being Tested
The purpose of the study is to compare the pharmacokinetics (PK) of bimekiz...
Status
Terminated
Location
Up0068 001
Start Date
2020-02-12
Trial ID
NCT04255862
Treatments Being Tested
The purpose of this study is to evaluate the effect of bimekizumab on gene ...
Status
Active Not Recruiting
Location
Ps0039 50140
Start Date
2024-07-29
Trial ID
NCT06506916
Treatments Being Tested
This is a study to assess the long-term safety, long-term efficacy and tole...
Status
Completed
Location
Pa0012 50017
Start Date
2019-08-13
Trial ID
NCT04009499
Treatments Being Tested
The purpose of the study is to compare the efficacy of bimekizumab versus r...
Status
Completed
Location
Pa0016 50662
Start Date
2024-10-21
Trial ID
NCT06624228
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of bimekizu...
Status
Completed
Location
As0013 908
Start Date
2017-10-04
Trial ID
NCT03215277
Treatments Being Tested
This is a study to compare the efficacy of bimekizumab versus adalimumab in...
Status
Completed
Location
Ps0008 957
Start Date
2018-01-26
Trial ID
NCT03412747
Treatments Being Tested